Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1756 AL 1770

Montreal Cognitive Assessment for the diagnosis of Alzheimer's disease and other dementias

Davis DH, Creavin ST, Yip JL, Noel-Storr AH, Brayne C, Cullum S.

Cochrane Database Syst Rev. 2015 Oct 29;2015(10):CD010775. doi: 10.1002/14651858.CD010775.pub2.

Speech intelligibility in Parkinson's disease patients with zona incerta deep brain stimulation

Sandström L, Hägglund P, Johansson L, Blomstedt P, Karlsson F.

Brain Behav. 2015 Sep 25;5(10):e00394. doi: 10.1002/brb3.394. eCollection 2015 Oct.

Handwriting as a marker for PD progression: a shift in paradigm

Pinto S, Velay JL.

Neurodegener Dis Manag. 2015 Oct;5(5):367-9. doi: 10.2217/nmt.15.29. Epub 2015 Oct 30.

Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease

Goldman JG, Aggarwal NT, Schroeder CD.

Neurodegener Dis Manag. 2015 Oct;5(5):425-43. doi: 10.2217/nmt.15.34. Epub 2015 Oct 30.

Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised

Sobreira E, Pena-Pereira MA, Eckeli AL, Sobreira-Neto MA, Chagas MH, Foss MP, Cholerton B, Zabetian CP, Mata IF, Tumas V.

Arq Neuropsiquiatr. 2015 Nov;73(11):929-33. doi: 10.1590/0004-282X20150156.

Oral Hygiene in Patients with Parkinson's Disease

Batista LM, Portela de Oliveira MT, Magalhaes WB, Bastos PL.

R I Med J (2013). 2015 Nov 2;98(11):35-7.

The TRIB3 Q84R polymorphism, insulin resistance and related metabolic alterations

Prudente S, Trischitta V.

Biochem Soc Trans. 2015 Oct;43(5):1108-11. doi: 10.1042/BST20150115.

Links among glaucoma, neurodegenerative, and vascular diseases of the central nervous system

Nucci C, Martucci A, Cesareo M, Garaci F, Morrone LA, Russo R, Corasaniti MT, Bagetta G, Mancino R.

Prog Brain Res. 2015;221:49-65. doi: 10.1016/bs.pbr.2015.04.010. Epub 2015 Jul 2.

Changes in plasma catecholamines levels as preclinical biomarkers in experimental models of Parkinson's disease

Kim AR, Ugryumov MV.

Dokl Biochem Biophys. 2015;464:308-11. doi: 10.1134/S1607672915050105. Epub 2015 Oct 31.

Cognitive training in Parkinson disease: A systematic review and meta-analysis

Leung IH, Walton CC, Hallock H, Lewis SJ, Valenzuela M, Lampit A.

Neurology. 2015 Nov 24;85(21):1843-51. doi: 10.1212/WNL.0000000000002145. Epub 2015 Oct 30.

More than just a movement disorder: Why cognitive training is needed in Parkinson disease

Ventura MI, Edwards JD, Barnes DE.

Neurology. 2015 Nov 24;85(21):1828-9. doi: 10.1212/WNL.0000000000002158. Epub 2015 Oct 30.

A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders

Gendelman HE, Mosley RL.

J Neuroimmune Pharmacol. 2015 Dec;10(4):645-50. doi: 10.1007/s11481-015-9639-4. Epub 2015 Oct 31.

[Research Progress of Pathogenesis and Treatment of Parkinsons Disease]

Liu J, Duan CL, Yang H.

Sheng Li Ke Xue Jin Zhan. 2015 Jun;46(3):163-9.

[The Function of Neuroinflammation in Parkinson Disease]

Li JY, Ma SS, Huang QY, Li MT.

Sheng Li Ke Xue Jin Zhan. 2015 Jun;46(3):175-9.

[The Role of Iron and Alpha-synuclein Interacting in Parkinson's Disease]

Wang J, Song N, Xu HM, Jiang H, Xie JX.

Sheng Li Ke Xue Jin Zhan. 2015 Jun;46(3):180-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias